GBA Fund Investment Limited - Net Worth and Insider Trading

GBA Fund Investment Limited Net Worth

The estimated net worth of GBA Fund Investment Limited is at least $201 Million dollars as of 2024-06-22. GBA Fund Investment Limited is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 13,854,690 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $201 Million. Details can be seen in GBA Fund Investment Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that GBA Fund Investment Limited has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).

Transaction Summary of GBA Fund Investment Limited

To

GBA Fund Investment Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, GBA Fund Investment Limited owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .

Click here to see the complete history of GBA Fund Investment Limited’s form 4 insider trades.

Insider Ownership Summary of GBA Fund Investment Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:01541 ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2023-09-05 2101 Beneficial owner

GBA Fund Investment Limited Latest Holdings Summary

GBA Fund Investment Limited currently owns a total of 1 stock. GBA Fund Investment Limited owns 13,854,690 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $201 Million.

Latest Holdings of GBA Fund Investment Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01541 ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2023-09-05 13,854,690 14.48 200,615,911

Holding Weightings of GBA Fund Investment Limited


GBA Fund Investment Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, GBA Fund Investment Limited has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 13,854,690 shares on September 5, 2023, which brought GBA Fund Investment Limited around $0.

Insider Trading History of GBA Fund Investment Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

GBA Fund Investment Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

GBA Fund Investment Limited Ownership Network

Ownership Network List of GBA Fund Investment Limited

No Data

Ownership Network Relation of GBA Fund Investment Limited

Insider Network Chart

GBA Fund Investment Limited Owned Company Details

What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?

Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?

GBA Fund Investment Limited is the 2101 Beneficial owner of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include Ho Yao , CHENG YIQUAN , and 2102 Investment manager LAV Asset Management (Hong Kong) Limited .

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary

Over the past 18 months, GBA Fund Investment Limited made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 0. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by LAV GP V, L.P. , a net sale of 0 shares made by Halo Biomedical LP , and a net sale of 0 shares made by CHENG YIQUAN .

In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions

No Available Data

GBA Fund Investment Limited Mailing Address

Above is the net worth, insider trading, and ownership report for GBA Fund Investment Limited. Currently GuruFocus does not have mailing address information for GBA Fund Investment Limited.

Discussions on GBA Fund Investment Limited

No discussions yet.